Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Redox Signal 16 , 1732 (2012)
Notable Studies: Efficacy and safety of liraglutide 3.0 mg in patients with overweight and obese with or without diabetes: a systematic review and meta-analysis Efficacy and safety of liraglutide for obesity and people who are overweight: a systematic review and meta-analysis of randomized controlled trials The effectiveness and safety of liraglutide in treating overweight/obese patients with polycystic ovary syndrome: a meta-analysis Also Known As: Victoza, Saxenda, Xultophy, NN2211, GTPL1133 Research Applications: Weight loss Metabolic syndrome PCOS Neuroprotection Risks: Nausea and gastrointestinal upset Injection site reactions Tachycardia Potentially pancreatitis and neoplasias FDA approval limited to T2D and overweight/obese patients Chemical Structure What is Liraglutide
We call [this drug] a physiological disruption akin to technological disruptions of our time like the smartphone
Never freeze Wegovy
